ADB-5’Br-BINACA is classified as a synthetic cannabinoid. Synthetic cannabinoids have been reported to cause psychoactive effects similar to delta-9-tetrahydrocannabinol (THC).
Little to no information is currently known about the activity, potency, and/or toxicity of ADB-5’Br-BINACA. New synthetic cannabinoids continue to emerge among the recreation drug supply internationally, seemingly as replacements after a synthetic cannabinoid class-wide
ban implemented by China in July 2021 which included most traditional indole and indazole structural scaffolds.1 Many of these new synthetic cannabinoid analogues are unstudied with pharmacological and human effects undetermined.
Currently, ADB-5’Br-BINACA is not a scheduled substance in the United States.